Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
Prospective Study of ALS Mortality Among World War II, Korea, and Vietnam Veterans.
2006-01-01

The authors prospectively assessed the association between Amyotrophic Lateral Sclerosis (ALS) mortality and self-reported military service in the American Cancer Society's Cancer Prevention Study II (CPS II) cohort, a cohort that includes over 500,000 me...

National Technical Information Service (NTIS)

2
Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer.
2011-08-12

BACKGROUND AND PURPOSE: We wanted to evaluate the efficacy, defined as 2-year disease-free survival (DFS), and safety of bevacizumab/chemoradiation in preoperative and adjuvant settings for patients with stage II/III rectal cancer. PATIENTS AND METHODS: Eligible patients had stage II/III rectal adenocarcinoma, Eastern Cooperative Oncology Group performance ...

PubMed

3
920 Articles | JNCI Vol. 99, Issue 12 | June 20, 2007 Drinking water in region II of Chile is supplied mainly by rivers

ratios for three birth cohorts com- paring region II with region V are presented in Fig. 3. Lung cancer ratios between the birth cohorts of women. For bladder cancer, high rate ratios can be seen for each (38). Third, the case�control study of lung cancers diagnosed in 1994� 1996 in region ...

E-print Network

4
Observational research methods. Research design II: cohort, cross sectional, and case-control studies
2003-01-01

Cohort, cross sectional, and case-control studies are collectively referred to as observational studies. Often these studies are the only practicable method of studying various problems, for example, studies of aetiology, instances where a randomised controlled trial might ...

PubMed Central

5
Cohort Consortium Members - EGRP

Nurses' Health Study II (NHS II) continues follow-up of more than 116,000 women who in 1989 were enrolled in a prospective study to evaluate potentially modifiable risk factors for major health problems among younger women. In this unique cohort, exposure information has been collected at ...

Cancer.gov

6
Chondroitin sulfate expression predicts poor outcome in breast cancer.
2011-08-17

Experimental studies have established that the sulfated glycosaminoglycans heparan sulfate and chondroitin sulfate act as co-receptors of cytokines and growth factors that drive the malignant cell phenotype and the remodelling of the surrounding tumor stroma. However, the clinical relevance of these studies remains ill-defined. The present ...

PubMed

7
Original Research Plan - BPC3 - EGRP

The Breast and Prostate Cancer and Hormone-Related Gene Variant Study allows large-scale analyses of breast and prostate cancer risk in relation to genetic polymorphisms and gene-environment interactions that affect hormone metabolism. The study combines the resources of six large prospective cohorts from the American Cancer Society ...

Cancer.gov

8
DEMONSTRATION OF LOW COST BURDEN, EXPOSURE MONITORING STRATEGIES FOR USE IN LONGITUDINAL COHORT STUDIES - VOLUME I - FINAL REPORT AND VOLUME II - APPENDICES

The Federal Government is currently planning a large, prospective birth cohort study known as the National Children's Study that will potentially involve 100,000 children and their families. The observation period will start as close to conception as possible and will continue f...

EPA Science Inventory

9
Increased nuchal translucency, normal karyotype and infant development.
2011-08-11

OBJECTIVE: To investigate, if chromosomally normal fetuses with a nuchal translucency (NT) ? 99(th) percentile (corresponding to 3.5 mm) in first trimester have an increased risk of delayed development at two years of age. METHODS: The study included children of women from ten Danish hospitals: children with an NT ? 99(th) percentile (cohort I) and ...

PubMed

10
Recognition of local glycoprotein misfolding by

, Math, Physics, and Speech and Hearing Student CR GR (regular) CLAS I CLAS II/ FPA MCECS SBA Cohort A SBA Cohort B SBA Cohort C GSSW: Distance Ed Fees GR (regular) CLAS I CLAS II and FPA MCECS SBA Cohort A SBA Cohort B SBA Cohort C ...

E-print Network

11
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
2011-09-19

BACKGROUND: This multicenter phase II trial evaluated the efficacy and safety of trabectedin in metastatic castration-resistant prostate cancer (CRPC). PATIENTS AND METHODS: Two schedules were evaluated in three cohorts: weekly as 3-h i.v. infusion at 0.58 mg/m(2) for 3 out of 4 weeks (Cohort A, n = 33), and every 3 weeks (q3wk) as ...

PubMed

12
PubH 6342 Epidemiologic Methods II

1 PubH 6342 Epidemiologic Methods II Course Syllabus Spring 2009 Credits: 3 Meeting Days: Tuesdays, and interpreting observational epidemiologic studies, including cohort, case-control, and cross-sectional studies. It is the second course in a four-course sequence on the theory and practice of epidemiology. This ...

E-print Network

13
Nurses' Health Study II: Risk Factors for Breast Cancer Among Younger Nurses - EGRP

Nurses' Health Study II (NHS II) continues follow-up of over 116,000 women who in 1989 were enrolled in a prospective study to evaluate potentially modifiable risk factors for major health problems among younger women. In this unique cohort, exposure information has been collected at 2-year ...

Cancer.gov

14
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
1998-06-01

Bolus 5-fluorouracil (5-FU) is a phase-specific drug with a short plasma half-life that is used in combination with bolus cyclophosphamide and methotrexate in the treatment of breast cancer. The efficacy of 5-FU can be improved by continuous intravenous infusion using portable infusion pumps (infusional 5-FU). Infusional 5-FU, 200 mg m(-2) day(-1), in combination with standard doses of bolus ...

PubMed Central

First Page Previous Page 1 Next Page Last Page